PL4243779T3 - Formulacja granulatu farmaceutycznego i sposób jej wytwarzania - Google Patents

Formulacja granulatu farmaceutycznego i sposób jej wytwarzania

Info

Publication number
PL4243779T3
PL4243779T3 PL21865370.7T PL21865370T PL4243779T3 PL 4243779 T3 PL4243779 T3 PL 4243779T3 PL 21865370 T PL21865370 T PL 21865370T PL 4243779 T3 PL4243779 T3 PL 4243779T3
Authority
PL
Poland
Prior art keywords
preparation
granulate formulation
pharmaceutical granulate
pharmaceutical
formulation
Prior art date
Application number
PL21865370.7T
Other languages
English (en)
Inventor
Sathyanarayana Vemula
Original Assignee
Pharmamatch B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamatch B.V. filed Critical Pharmamatch B.V.
Publication of PL4243779T3 publication Critical patent/PL4243779T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
PL21865370.7T 2020-11-16 2021-11-16 Formulacja granulatu farmaceutycznego i sposób jej wytwarzania PL4243779T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2026905A NL2026905B1 (en) 2020-11-16 2020-11-16 Pharmaceutical granulate formulation and method for the preparation thereof
PCT/NL2021/050703 WO2022103269A2 (en) 2020-11-16 2021-11-16 Pharmaceutical granulate formulation and method for the preparation thereof

Publications (1)

Publication Number Publication Date
PL4243779T3 true PL4243779T3 (pl) 2026-03-23

Family

ID=74096018

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21865370.7T PL4243779T3 (pl) 2020-11-16 2021-11-16 Formulacja granulatu farmaceutycznego i sposób jej wytwarzania

Country Status (4)

Country Link
EP (1) EP4243779B1 (pl)
NL (1) NL2026905B1 (pl)
PL (1) PL4243779T3 (pl)
WO (1) WO2022103269A2 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
BRPI0818177B1 (pt) 2007-10-04 2022-09-27 The Curators Of The University Of Missouri Aparelho
ES2549127T1 (es) * 2014-03-10 2015-10-23 Galenicum Health S.L. Composiciones farmacéuticas que comprenden un principio activo
PL3256107T3 (pl) 2015-02-09 2021-03-22 Rivopharm Sa Preparat farmaceutyczny racekadotrylu

Also Published As

Publication number Publication date
EP4243779B1 (en) 2025-12-31
EP4243779C0 (en) 2025-12-31
WO2022103269A2 (en) 2022-05-19
EP4243779A2 (en) 2023-09-20
WO2022103269A3 (en) 2022-06-23
NL2026905B1 (en) 2022-06-30

Similar Documents

Publication Publication Date Title
ZA202306105B (en) Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof
IL289925B2 (en) A derivative of adenosine and a pharmaceutical preparation containing it
EP3714887A4 (en) PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION AND RELATED PREPARATION PROCESS
EP3295952A4 (en) Pharmaceutical formulation comprising glp-1 analogue and preparation method thereof
PL4079734T3 (pl) Pochodna triazolopirydyny, sposób jej wytwarzania, jej kompozycja farmaceutyczna oraz jej zastosowanie
IL276244A (en) A pharmaceutical preparation for the eyes, a method for its preparation and its application
EP3244900A4 (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
IL288531A (en) Broad-spectrum antibacterial pharmaceutical formulations comprising lyses and methods of using them
EP3554486A4 (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF GLAUCOMA AND METHODS OF MAKING AND USING SAME
GB2576694B (en) Pharmaceutical product preparation device and method
GB202010230D0 (en) Pharmaceutical formulation
EP3749370C0 (de) Pharmazeutische formulierungen, verfahren zum herstellen einer pharmazeutischen formulierung sowie ein arzneimittel umfassend eine solche
EP3450450A4 (en) VANCOMYCINE DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3347022A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING DUTASTERIDE AND FORMULATION IN CAPSULE COMPRISING SAME
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
EP3813842A4 (en) PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCESS THEREOF
GB2595140B (en) Flupentixol/melitracen pharmaceutical composition and preparation thereof
GB2595141B (en) Flupentixol melitracen tablet and preparation method therefor
EP3424521A4 (en) PHARMACEUTICAL COMPOSITION AND PRODUCTION METHOD THEREFOR
GB202100526D0 (en) Pharmaceutical formulation
PL3960240T3 (pl) Preparat farmaceutyczny i sposób jego wytwarzania
EP3381467A4 (en) PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION
EP4034120A4 (en) SOLID ORAL PHARMACEUTICAL FORMULATIONS COMPRISING SAPROPTERIN DICHLORHYDRATE AND AT LEAST ONE PHARMACEUTICAL EXCIPIENT
IL297081A (en) Pharmaceutical formulation
EP3269709A4 (en) N-phenyl-n'-phenoxycarbonyl-phenylsulfonhydrazide derivative and pharmaceutical composition comprising same